|
2024
|
P/S
|
Pharmaceutical preparations and substances. |
|
|
P/S
|
Pharmaceutical preparations and substances for use in oncology. |
|
|
P/S
|
Pharmaceutical preparations and substances for the treatment of immune-mediated inflammatory dise... |
|
|
P/S
|
Pharmaceutical preparations and substances for use in oncology |
|
|
P/S
|
Pharmaceutical preparations and substances |
|
2023
|
P/S
|
Pharmaceutical preparations and substances for the treatment
of amyloidosis. |
|
|
P/S
|
Pharmaceutical preparations and substances for the treatment of amyloidosis. |
|
|
P/S
|
Pharmaceutical preparations and substances. |
|
|
Invention
|
Methods of treating heart failure with preserved ejection fraction employing dapagliflozin and co... |
|
|
Invention
|
Treatment of lupus. The disclosure relates to methods and compositions for the treatment of syste... |
|
|
Invention
|
Pharmaceutical composition.
The invention concerns pharmaceutical compositions containing a hydr... |
|
|
Invention
|
Perfusion bioreactor tangential flow filtration. Provided herein are systems and methods of enhan... |
|
|
P/S
|
Pharmaceutical preparations and substances for the treatment of amyloidosis. |
|
|
P/S
|
Pharmaceutical preparations and substances. Medical devices, namely, inhalers. |
|
|
Invention
|
Pcsk9 inhibitors and methods of use thereof. A compound with the Formula (I): A-B-C wherein A is ... |
|
|
Invention
|
Chemical compounds.
The present invention relates to azaquinolone compounds of Formula (I), and ... |
|
|
Invention
|
Compositions and methods for treating advanced solid tumors. Disclosed are methods for treating s... |
|
|
Invention
|
Combination of sglt2 inhibitors and mineralcorticoid receptor modulators for use in treatment of ... |
|
|
Invention
|
Pharmaceutical formulations.
A pharmaceutical formulation which comprises Compound 1, one or mor... |
|
|
Invention
|
Pharmaceutical formulation. A pharmaceutical formulation which comprises Compound 1, one or more ... |
|
|
Invention
|
Process for the preparation of substituted pyrrolopyrimidines and intermediates. There is provide... |
|
|
Invention
|
Pharmaceutical process and intermediates.
There is provided a new and improved synthetic route f... |
|
|
Invention
|
Inhibitors of myeloperoxidase. The specification generally relates to compounds of Formula (I), (... |
|
|
Invention
|
Certain (2s)-n-[(1s)-1-cyano-2-phenylethyl]-1,4-oxazepane-2-carboxamides for treating bronchiecta... |
|
|
Invention
|
Mta-cooperative prmt5 inhibitors for use in the treatment of cancer. MTAPMTAP gene cancers compri... |
|
|
Invention
|
Combination therapies for treatment of cirrhosis with portal hypertension.
A method of treating ... |
|
|
Invention
|
Combination therapies for treatment of cirrhosis with portal hypertension. Composition comprising... |
|
|
Invention
|
Protein kinase b inhibitors.
The invention relates to a novel group of compounds of Formula (I) ... |
|
|
Invention
|
Methods for detecting metabolites using a microfluidic-based ce-ms system. The present disclosure... |
|
|
Invention
|
Combinations of recombinant virus expressing interleukin-12 with pd-1/pd-l1 inhibitors. The prese... |
|
|
Invention
|
Combination treatment.
The present invention relates to methods for treating ischemic events in ... |
|
|
Invention
|
Pcsk9 inhibitors and methods of use thereof. Disclosed herein are PCSK9 inhibitors. Also disclose... |
|
|
Invention
|
Amino-triazolopyridine compounds and their use in treating cancer.
The specification generally r... |
|
|
Invention
|
Epidermal growth factor receptor tyrosine kinase inhibitors in combination with hgf-receptor inhi... |
|
|
Invention
|
Treatment for immuno-oncology resistant subjects with an anti pd-l1 antibody an antisense targete... |
|
|
Invention
|
Anti-pcrv and psl bispecific antibodies for treatment of bronchiectasis. PseudomonasPseudomonas P... |
|
|
Invention
|
Combinations involving epidermal growth factor receptor tyrosine kinase inhibitors for the treatm... |
|
|
P/S
|
Pharmaceutical preparations and substances for the treatment of amyloidosis |
|
|
Invention
|
N-(2-(4-cyanothiazolidin-3-yl)-2-oxoethyl)- 6-morpholinoquinoline-4-carboxamide. NN-(2-(4-cyanoth... |
|
|
Invention
|
N-(2-(3-cyano-2-azabicyclo[3.1.0]hexan-2-yl)-2-oxoethyl)- quinoline-4-carboxamides. Compounds hav... |
|
|
Invention
|
N-(2-(4-cyanothiazolidin-3-yl)-2-oxoethyl)- quinoline-4-carboxamides. Compounds having the struct... |
|
|
Invention
|
N-(2-(3-cyano-2-azabicyclo[3.1.0]hexan-2-yl)-2-oxoethyl)quinoline-4-carboxamides.
Compounds havi... |
|
|
Invention
|
Therapeutic dendrimers.
Disclosed are dendrimers of formula (I):
Disclosed are dendrimers of f... |
|
|
Invention
|
Combination therapy for treating cancer. The present provides a method of treating ovarian cancer... |
|
|
Invention
|
Systems and methods for end to end continuous downstream processing. Provided herein are methods ... |
|
|
Invention
|
Rxfp1 modulators for treating resistant hypertension or heart failure with pulmonary hypertension... |
|
|
Invention
|
Solid forms of rxfp1 modulators. The specification generally relates to solid forms, for example,... |
|
|
Invention
|
Combinations of rxfp1 modulators and sglt2 inhibitors. The specification generally relates to com... |
|
|
Invention
|
Heteroaromatic compounds.
The specification relates to compounds of Formula (1):
The specifica... |
|
|
Invention
|
Pcsk9 inhibitors and methods of use thereof.
The invention relates to a novel inhibitor pharmaco... |
|
2022
|
P/S
|
Pharmaceutical preparations for use in oncology; Pharmaceutical preparations and substances for t... |
|
|
P/S
|
Pharmaceutical preparations and substances for use in oncology; Pharmaceutical preparations and s... |
|
|
Invention
|
Methods for treating small cell lung cancer and other neuroendocrine cancers.
The current disclo... |
|
|
Invention
|
New method to pronostic lung cancer.
The present invention relates to the field of prognostic of... |
|
|
Invention
|
Clinical endpoint adjudication system and method.
The present disclosure relates to a system and... |
|
|
Invention
|
Graph construction and visualization of multiplex immunofluorescence images.
Provided herein are... |
|
2021
|
Invention
|
N-(2-(4-cyanothiazolidin-3-yl)-2-oxoethyl)-quinoline-4-carboxamides.
Compounds having the struct... |
|
|
Invention
|
Oral formulation of a therapeutic compound.
The present invention provides a pharmaceutical tabl... |
|
|
Invention
|
Automated assessment of wound tissue.
A method of assessing a wound in a subject is provided. Th... |
|
|
Invention
|
Adjuvant durvalumab in combination with chemotherapy for treatment of cancer.
The disclosure gen... |
|
|
Invention
|
Treatment of flares in lupus.
The disclosure relates to methods and compositions for the treatme... |
